- Research Article
1,024- 10.1016/s1470-2045(14)70473-5
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- Oct 15, 2014
- The Lancet Oncology
- Sung Hoon Noh + 16 more +16
